NCT02953730View on ClinicalTrials.gov

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

PHASE4CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

June 30, 2016

Conditions
Acute Lymphoid Leukemia
Interventions
DRUG

PEG-rhG-CSF

Trial Locations (1)

300020

Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin

All Listed Sponsors
lead

Chinese Academy of Medical Sciences

OTHER

NCT02953730 - The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents | Biotech Hunter | Biotech Hunter